Physician profile
Christina Pratt
NPI 1124466800
$7,052.67
in general payments reported to CMS, 2019-2025
33 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $527 · 2020: $586 · 2021: $1,825 · 2022: $2,617 · 2023: $893 · 2024: $400 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,498.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,986.00 | 2019-2025 | Citrefix, Viaflow, Prostep |
| Integra Lifesciences Corporation | $920.26 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Anika Therapeutics, INC. | $888.53 | 2022 | |
| Treace Medical Concepts, INC. | $756.86 | 2021-2022 | |
| Medshape, INC. | $471.77 | 2022 | |
| Encore Medical, LP | $286.39 | 2021-2022 | |
| Smith+Nephew, INC. | $283.25 | 2019-2022 | |
| Kerecis Limited | $238.30 | 2021-2022 | |
| Trilliant Surgical LLC. | $156.01 | 2022 | |
| Orthofix Medical, INC. | $147.00 | 2019 | |
| Solventum Corporation | $140.78 | 2025 | Prevena, V.A.C.Ulta, Activ.A.C. |
| Paragon 28, INC. | $123.41 | 2023-2024 | Monkey Rings, Mtp |
| Medtronic Vascular, INC. | $72.33 | 2019 | |
| Medtronic, INC. | $60.24 | 2021 | |
| Organogenesis INC. | $56.91 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lightforce Orthodontics, INC. | $55.52 | 2023 | |
| Arteriocyte Medical Systems, INC. | $40.97 | 2019-2021 | |
| Bioventus LLC | $35.43 | 2020 | |
| Aroa Biosurgery Incorporated | $34.51 | 2024 | |
| Grt US Holding, INC. | $34.43 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $34.32 | 2021 | |
| Rock Medical Orthopedics, INC. | $30.97 | 2023 | |
| Arthrosurface Incorporated | $28.27 | 2020 | |
| Triad Life Sciences INC. | $24.69 | 2022 | |
| Nevro Corp. | $23.83 | 2022 | |
| Convatec INC. | $21.58 | 2020 | |
| Heron Therapeutics, INC. | $16.66 | 2022 | |
| Boston Scientific Corporation | $16.01 | 2019 | |
| Alafair Biosciences, INC. | $15.50 | 2022 | |
| Nabriva Therapeutics, Plc | $14.41 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $14.11 | 2021 | |
| Horizon Therapeutics Plc | $12.51 | 2021 | |
| Acell, INC. | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Pratt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.